UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas

Annals of oncology, 2020-05, Vol.31 (5), p.599-608

2020

Volltextzugriff (PDF)

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Annals of oncology, 2018-10, Vol.29 (10), p.2085-2091

2018

Volltextzugriff (PDF)

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers

Annals of oncology, 2016-07, Vol.27 (7), p.1286-1291

2016

Volltextzugriff (PDF)

Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells

Genes & development, 1999-06, Vol.13 (11), p.1398-1411

1999

Volltextzugriff (PDF)

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (21), p.1976-1986

2018

Volltextzugriff (PDF)

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

The New England journal of medicine, 2018-05, Vol.378 (21), p.1976-1986

2018

Volltextzugriff (PDF)

OA20.05 The International Association for the Study of Lung Cancer Grading System for Recurrence and Lung Cancer-Specific Survival

Journal of thoracic oncology, 2023-11, Vol.18 (11), p.S91-S92

2023

Volltextzugriff (PDF)

1385P Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers

Annals of oncology, 2023-10, Vol.34, p.S794-S795

2023

Volltextzugriff (PDF)

OA06.01 Validation of the 8th Ed TNM: Invasive Size for Pathologic T Descriptor in Stage I-IIA Resected Nonmucinous Adenocarcinomas

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S855-S856

2021

Volltextzugriff (PDF)

EP16.03-030 AKT Inhibition as a Therapeutic Strategy to Constrain Histological Transdifferentiation in EGFR-mutant Lung Adenocarcinoma

Journal of thoracic oncology, 2022-09, Vol.17 (9), p.S602

2022

Volltextzugriff (PDF)

P38.04 3D Analysis of Spread Through Air Spaces in Squamous Cell Carcinoma and Carcinoid Tumor Using Whole Block Imaging by Micro CT

Journal of thoracic oncology, 2021-03, Vol.16 (3), p.S458-S459

2021

Volltextzugriff (PDF)

ES12.05 Impact of STAS in Lung Cancer Staging

Journal of thoracic oncology, 2019-10, Vol.14 (10), p.S45-S45

2019

Volltextzugriff (PDF)

OA18.06 Characteristics and Outcomes of Patients with SMARCA4-Deficient Undifferentiated Thoracic Tumors

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S51-S51

2024

Volltextzugriff (PDF)

Mucocutaneous bullous amyloidosis with an unusual mixed protein composition of amyloid deposits

British journal of dermatology (1951), 2006-04, Vol.154 (4), p.751-754

2006

Volltextzugriff (PDF)

P3.03I.07 Comprehensive Pan-Cancer Analysis of Oncogenic MET Rearrangements with a Focus on Targetability in NSCLC

Journal of thoracic oncology, 2024-10, Vol.19 (10), p.S312-S312

2024

Volltextzugriff (PDF)

MA22.05 Impact of Tumor Spread Through Air Spaces (STAS) in Lung Neuroendocrine Tumors (NETs)

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S434-S435

2018

Volltextzugriff (PDF)

MS10.04 Therapeutic Implications of Spread Through Air Spaces (STAS)

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S265-S266

2018

Volltextzugriff (PDF)

MA09.06 The Newly Recognized Filigree Pattern of Micropapillary (MIP) Lung Adenocarcinoma (LADC) is as Clinically Important as the Classical Pattern

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S386-S387

2018

Volltextzugriff (PDF)

1MO Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation

Annals of oncology, 2021-10, Vol.32, p.S1345

2021

Volltextzugriff (PDF)

1800O Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

Annals of oncology, 2021-09, Vol.32, p.S1226-S1226

2021

Volltextzugriff (PDF)

OA03.07 Three-Dimensional Immunofluorescence Analysis of Dynamic Vessel Co-Option of Spread Through Air Spaces (STAS) in Lung Cancer

Journal of thoracic oncology, 2018-10, Vol.13 (10), p.S327-S327

2018

Volltextzugriff (PDF)

MA11.06 Multi-Omic Characterization of Lung Tumors Implicates AKT and MYC Signaling in Adenocarcinoma to Squamous Cell Transdifferentiation

Journal of thoracic oncology, 2021-10, Vol.16 (10), p.S919-S919

2021

Volltextzugriff (PDF)

OA 18.06 Three-Dimensional Assessment of Spread Through Air Spaces in Lung Adenocarcinoma: Insights and Implications

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S1797-S1797

2017

Volltextzugriff (PDF)

P3.13-019 Preoperative Needle Biopsy Does Not Increase the Risk of Pleural Recurrence in ≤3cm Lung Adenocarcinoma

Journal of thoracic oncology, 2017-11, Vol.12 (11), p.S2323-S2323

2017

Volltextzugriff (PDF)

A07 The Genomic Landscape of SMARCA4 Alterations and Association with Patient Outcomes in Lung Cancer

Journal of thoracic oncology, 2020-02, Vol.15 (2), p.S14-S14

2020

Volltextzugriff (PDF)

1 – 25 von 112

Suche als RSS-Feed

Aktive Filter

KollektionTaylor & Francis

ThemaAntineoplastic Combined Chemotherapy Protocols - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(89)

Publikationsform

Sprache

Englisch
(93)
Russisch
(20)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Clinical and molecular correlates of PD-L1 expression in patients with lung adenocarcinomas

PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers

Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancers

Direct interaction of hematopoietic transcription factors PU.1 and GATA-1: functional antagonism in erythroid cells

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

Neoadjuvant PD-1 Blockade in Resectable Lung Cancer

OA20.05 The International Association for the Study of Lung Cancer Grading System for Recurrence and Lung Cancer-Specific Survival

1385P Genomics of early progression on selpercatinib in patients with RET fusion-positive lung cancers

OA06.01 Validation of the 8th Ed TNM: Invasive Size for Pathologic T Descriptor in Stage I-IIA Resected Nonmucinous Adenocarcinomas

EP16.03-030 AKT Inhibition as a Therapeutic Strategy to Constrain Histological Transdifferentiation in EGFR-mutant Lung Adenocarcinoma

P38.04 3D Analysis of Spread Through Air Spaces in Squamous Cell Carcinoma and Carcinoid Tumor Using Whole Block Imaging by Micro CT

ES12.05 Impact of STAS in Lung Cancer Staging

OA18.06 Characteristics and Outcomes of Patients with SMARCA4-Deficient Undifferentiated Thoracic Tumors

Mucocutaneous bullous amyloidosis with an unusual mixed protein composition of amyloid deposits

P3.03I.07 Comprehensive Pan-Cancer Analysis of Oncogenic MET Rearrangements with a Focus on Targetability in NSCLC

MA22.05 Impact of Tumor Spread Through Air Spaces (STAS) in Lung Neuroendocrine Tumors (NETs)

MS10.04 Therapeutic Implications of Spread Through Air Spaces (STAS)

MA09.06 The Newly Recognized Filigree Pattern of Micropapillary (MIP) Lung Adenocarcinoma (LADC) is as Clinically Important as the Classical Pattern

1MO Multi-omic characterization of lung tumors identify AKT and EZH2 as potential therapeutic targets in adenocarcinoma-to-squamous transdifferentiation

1800O Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

OA03.07 Three-Dimensional Immunofluorescence Analysis of Dynamic Vessel Co-Option of Spread Through Air Spaces (STAS) in Lung Cancer

MA11.06 Multi-Omic Characterization of Lung Tumors Implicates AKT and MYC Signaling in Adenocarcinoma to Squamous Cell Transdifferentiation

OA 18.06 Three-Dimensional Assessment of Spread Through Air Spaces in Lung Adenocarcinoma: Insights and Implications

P3.13-019 Preoperative Needle Biopsy Does Not Increase the Risk of Pleural Recurrence in ≤3cm Lung Adenocarcinoma

A07 The Genomic Landscape of SMARCA4 Alterations and Association with Patient Outcomes in Lung Cancer

Aktive Filter

Suchergebnisse filtern